Report 23100815
Luna Institute of Technology
Cardiology Branch of the Medical Division
Dr. Ken Jackson
Abraham Gwan is an Arabian-Korean male, age 55, occupation spacecraft technician. On May 7th, 2310, he arrived on AU Luna after a two-month long voyage on the AUS Bradwell’s Dawn, which started from New Austin of the New Texas System. Details of the voyage can be found on the Dawn’s travel records, attached in Appendix A. Mr. Gwan participated in a full body scan overseen by Dr. Charles Mcmahon, who identified an anomaly on the surface of the patient’s heart using the Insight-C10, developed by Medical Solutions. Additional details of the machine are attached in Appendix B. The anomaly was identified as only a micrometer in diameter, by default passed off as an error by the computer itself. However, Dr. Mcmahon decided to pursue further into the matter, gaining Mr. Gwan’s permission to conduct an open-surgery analysis.
The anomaly turned out to be true and physical, identified as A1 in this report. A1 is a small, smooth, circular disk barely 1 micrometer in diameter and roughly 0.1 micrometers thin. Visibly, it is also black and metallic. Astonishingly, A1’s atomic structure is highly complex, made of carbon, silicon, iron and a range of super-heavy elements that were previously only found present in labs. A1’s function is currently unknown, other than that it attached to the surface of the patient’s heart.
Patient Mr. Gwan reported no physical or mental ailments that couldn’t be described by the normal side effects of space travel, including nausea, claustrophobia, and bone marrow loss. Subjecting lab grown human tissue to A1 also yielded no additional effects beyond physical interaction between the cells and the metallic disk.
After the successful removal of A1 from the patient’s heart, medical records of those aboard Bradwell’s Dawn were obtained, which expanded to anyone who participated in FTL travel in the past six months. 20% of the sample size included full body scans using the Insight-C10 or similarly up-to-date machines. Of those, a further 15% returned positive anomaly identifications on the surface of the heart, all of which were passed off as errors. The presence of A1 cannot be found in medical records of those who haven’t participated in FTL travel. These figures indicate a curious side effect of FTL travel on the human body that was previously undetectable.
Without any apparent negative effects on the human body, physicians are advised to inform their patients of the presence of A1 on their hearts, but also to advise against surgical removal such that long term effects can be studied. For now, the growth of A1 on the human heart as a result of FTL travel is dubbed cardiolithiasis, or Heart stone disease.
Luna Institute of Technology
Cardiology Branch of the Medical Division
Dr. Ken Jackson
Abraham Gwan is an Arabian-Korean male, age 55, occupation spacecraft technician. On May 7th, 2310, he arrived on AU Luna after a two-month long voyage on the AUS Bradwell’s Dawn, which started from New Austin of the New Texas System. Details of the voyage can be found on the Dawn’s travel records, attached in Appendix A. Mr. Gwan participated in a full body scan overseen by Dr. Charles Mcmahon, who identified an anomaly on the surface of the patient’s heart using the Insight-C10, developed by Medical Solutions. Additional details of the machine are attached in Appendix B. The anomaly was identified as only a micrometer in diameter, by default passed off as an error by the computer itself. However, Dr. Mcmahon decided to pursue further into the matter, gaining Mr. Gwan’s permission to conduct an open-surgery analysis.
The anomaly turned out to be true and physical, identified as A1 in this report. A1 is a small, smooth, circular disk barely 1 micrometer in diameter and roughly 0.1 micrometers thin. Visibly, it is also black and metallic. Astonishingly, A1’s atomic structure is highly complex, made of carbon, silicon, iron and a range of super-heavy elements that were previously only found present in labs. A1’s function is currently unknown, other than that it attached to the surface of the patient’s heart.
Patient Mr. Gwan reported no physical or mental ailments that couldn’t be described by the normal side effects of space travel, including nausea, claustrophobia, and bone marrow loss. Subjecting lab grown human tissue to A1 also yielded no additional effects beyond physical interaction between the cells and the metallic disk.
After the successful removal of A1 from the patient’s heart, medical records of those aboard Bradwell’s Dawn were obtained, which expanded to anyone who participated in FTL travel in the past six months. 20% of the sample size included full body scans using the Insight-C10 or similarly up-to-date machines. Of those, a further 15% returned positive anomaly identifications on the surface of the heart, all of which were passed off as errors. The presence of A1 cannot be found in medical records of those who haven’t participated in FTL travel. These figures indicate a curious side effect of FTL travel on the human body that was previously undetectable.
Without any apparent negative effects on the human body, physicians are advised to inform their patients of the presence of A1 on their hearts, but also to advise against surgical removal such that long term effects can be studied. For now, the growth of A1 on the human heart as a result of FTL travel is dubbed cardiolithiasis, or Heart stone disease.
